Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety、Immunogenicity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05615974
What this trial is testing

A Phase I/II Study of LM-101 Injection in Patients With Advanced Malignant Tumors

Who this might be right for
Malignant Tumors
LaNova Medicines Limited 139
Early research (Phase 1)UnknownNCT04268420
What this trial is testing

A Trial For The Study of Falciparum Malaria Protein 013 Administered Via Intramuscular Injection in Healthy Adults

Who this might be right for
Vaccine Reaction
U.S. Army Medical Research and Development Command 46
Large-scale testing (Phase 3)Study completedNCT03731182
What this trial is testing

Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Children With Sickle Cell Disease (V114-023/PNEU-SICKLE)

Who this might be right for
Pneumococcal Infections
Merck Sharp & Dohme LLC 104
Large-scale testing (Phase 3)Study completedNCT01878825
What this trial is testing

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Trivalent Split Virion Influenza Vaccine Fluviral™ (2013-2014 Season) in Adults Aged 18 Years and Older

Who this might be right for
Influenza
GlaxoSmithKline 121
Large-scale testing (Phase 3)WithdrawnNCT05229068
What this trial is testing

Safety, Reactogenicity and Immune Response of the Repeat Vaccination Against RSV When Given to Female Participants of 18-49 Years of Age During Their Subsequent Uncomplicated Pregnancy

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline
Large-scale testing (Phase 3)UnknownNCT04895020
What this trial is testing

Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years

Who this might be right for
HPV InfectionsCervical CancerVulvar Cancer+12 more
Shanghai Bovax Biotechnology Co., Ltd. 1,200
Early research (Phase 1)Study completedNCT04227210
What this trial is testing

Safety and Immune Response to an Investigational Vaccine Against Respiratory Syncytial Virus in Healthy Adults

Who this might be right for
Respiratory Syncytial Virus Infections
Meissa Vaccines, Inc. 20
Testing effectiveness (Phase 2)Study completedNCT01473810
What this trial is testing

Intranasal Modified Vacc-4x Gag Peptides With Endocine as Adjuvant

Who this might be right for
HIV Infection
Oslo University Hospital 24
Early research (Phase 1)Ended earlyNCT04793620
What this trial is testing

Pertussis Acellular Vaccine Adjuvanted With TQL1055

Who this might be right for
Pertussis
Adjuvance Technologies, Inc. 72
Post-approval studies (Phase 4)Study completedNCT00755274
What this trial is testing

Annual Study for Serum Collection for Immunogenicity and Safety Evaluation in Healthy Children Receiving Fluzone®

Who this might be right for
InfluenzaOrthomyxoviridae Infections
Sanofi Pasteur, a Sanofi Company 32
Early research (Phase 1)Study completedNCT04591717
What this trial is testing

COVID-19 Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenoviral-COVID-19 in Normal Healthy Volunteers

Who this might be right for
COVID-19
ImmunityBio, Inc. 34
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07168018
What this trial is testing

Safety and Immunogenicity of Coadministration of the Candidate Rabies Vaccine ChAdOx2 RabG and Licensed Vaccine

Who this might be right for
Rabies
University of Oxford 40
Testing effectiveness (Phase 2)Looking for participantsNCT07244510
What this trial is testing

Efficacy and Safety of SCT650C in Participants With Moderate to Severe Hidradenitis Suppurativa

Who this might be right for
Hidradenitis Suppurativa (HS)
Sinocelltech Ltd. 60
Testing effectiveness (Phase 2)Study completedNCT02719743
What this trial is testing

A Dose Ranging Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' GSK1557484A Vaccine in Children 6 to Less Than 36 Months of Age

Who this might be right for
Influenza
GlaxoSmithKline 185
Early research (Phase 1)Study completedNCT06674525
What this trial is testing

Evaluation of 626 in Healthy Adult Subjects

Who this might be right for
Healthy Subjects (HS)
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 50
Early research (Phase 1)Study completedNCT01594320
What this trial is testing

A/H5N1 Virus-Like Particle Antigen Dose Ranging Study With Adjuvant 1

Who this might be right for
Influenza (Pandemic)
Novavax 333
Early research (Phase 1)Study completedNCT05409196
What this trial is testing

Phase 1 Trial for Safety, Tolerability, and Immunogenicity of a Live, Attenuated, Oral Shigella/ETEC Combination Vaccine to Healthy Adults

Who this might be right for
Diarrheal Disease, InfectiousGastrointestinal DiseaseReactive Arthritis
Eveliqure Biotechnologies GmbH 84
Early research (Phase 1)Study completedNCT05518201
What this trial is testing

Evaluate the Safety and Immunogenicity of a 9-valent HPV Vaccine in Chinese Healthy Male Aged 9-45 Year-old

Who this might be right for
Penile CancerAnal CancerPIN-1+6 more
Shanghai Bovax Biotechnology Co., Ltd. 90
Early research (Phase 1)Study completedNCT00685412
What this trial is testing

Phase I of Human Papillomavirus (HPV) DNA Plasmid (VGX-3100) + Electroporation for CIN 2 or 3

Who this might be right for
Papillomavirus Infections
Inovio Pharmaceuticals 18
Early research (Phase 1)Study completedNCT00001906
What this trial is testing

Safety and Immunogenicity of a Vaccine for Cutaneous Leishmaniasis Using Recombinant Human Interleukin-12 and Aluminum Hydroxide Gel as Adjuvants

Who this might be right for
Cutaneous Leishmaniasis
National Institute of Allergy and Infectious Diseases (NIAID) 50
Next Page